Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
9.38
-0.22 (-2.29%)
At close: Nov 18, 2026, 4:00 PM EST
9.24
-0.14 (-1.49%)
Pre-market: Nov 19, 2026, 4:01 AM EST
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $622.71 million as of November 18, 2026. It is the 12,540th most valuable company in the world and the 2,516th biggest in the United States. Its market cap has decreased by 24.47% in one year.
Market Cap
622.71M
Enterprise Value
181.25M
1-Year Change
-24.47%
Global Rank
Country Rank
#2,516 United States
Category
ChartMarket Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has decreased from $931.70M to $622.71M, a decrease of -33.16%. That is a compound annual growth rate of -16.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 622.71M | -32.46% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annexon | 661.95M |
| Nuvectis Pharma | 660.27M |
| Janux Therapeutics | 655.27M |
| Geron | 644.24M |
| Olema Oncology | 632.52M |
| Design Therapeutics | 630.12M |
| Alumis | 628.33M |
| DBV Technologies | 624.05M |